Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Block

Showing results (431-440 of 540) with videos related to

Pageof 54
Sort By:
Current Medical Research and Opinion|September 14, 2006
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young childrenStan L Block, Jordana K Schmier, Gerard F Notario, et al.
The Pediatric Infectious Disease Journal|December 1, 1993
Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky childrenS L Block, J A Hedrick, R D Tyler, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis mediaAntonio Arrieta, Adriano Arguedas, Pilar Fernandez, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2006
Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stressSufen Yang, Jun Yang, Zhengqin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2013
Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormoneUndine Schubert, Janine Schmid, Susann Lehmann, et al.
Journal of Hepatology|January 1, 1993
Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overviewD R Nalin, B J Kuter, L Brown, et al.
Clinical Therapeutics|September 1, 2004
Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trialBenjamin Torum, Stan L Block, Hugo Avila, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 functionLuca Szalontay, Andrew V Schally, Petra Popovics, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survivalVictoria Florea, Sonia S Majid, Rosemeire M Kanashiro-Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2014
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsMiklos Jaszberenyi, Ferenc G Rick, Petra Popovics, et al.
Pageof 54

Showing results (431-440 of 540) with videos related to

Sort By:
Pageof 54
Current Medical Research and Opinion|September 14, 2006
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young childrenStan L Block, Jordana K Schmier, Gerard F Notario, et al.
The Pediatric Infectious Disease Journal|December 1, 1993
Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky childrenS L Block, J A Hedrick, R D Tyler, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis mediaAntonio Arrieta, Adriano Arguedas, Pilar Fernandez, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2006
Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stressSufen Yang, Jun Yang, Zhengqin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2013
Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormoneUndine Schubert, Janine Schmid, Susann Lehmann, et al.
Journal of Hepatology|January 1, 1993
Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overviewD R Nalin, B J Kuter, L Brown, et al.
Clinical Therapeutics|September 1, 2004
Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trialBenjamin Torum, Stan L Block, Hugo Avila, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 functionLuca Szalontay, Andrew V Schally, Petra Popovics, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survivalVictoria Florea, Sonia S Majid, Rosemeire M Kanashiro-Takeuchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2014
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsMiklos Jaszberenyi, Ferenc G Rick, Petra Popovics, et al.
Pageof 54